Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous aspirin in a porcine model.

[1]  J. Eppler,et al.  Protein binding of acetylsalicylic acid and salicylic acid in porcine and human serum. , 1995, Veterinary and human toxicology.

[2]  M. Tenenbein,et al.  Multiple-dose charcoal and whole-bowel irrigation do not increase clearance of absorbed salicylate. , 1992, Archives of internal medicine.

[3]  M. Tenenbein.  Multiple doses of activated charcoal: time for reappraisal? , 1991, Annals of emergency medicine.

[4]  G. Koren,et al.  Decreased protein binding of salicylates in Kawasaki disease. , 1991, The Journal of pediatrics.

[5]  L. Kirshenbaum,et al.  Does multiple-dose charcoal therapy enhance salicylate excretion? , 1990, Archives of Internal Medicine.

[6]  H. Kelly,et al.  Repeated oral administration of activated charcoal for treating aspirin overdose in young children. , 1990, Pediatrics.

[7]  G. Dickinson,et al.  An Evaluation of the Effect of Repeated Doses of Oral Activated Charcoal on Salicylate Elimination , 1989, Journal of clinical pharmacology.

[8]  L. Prescott,et al.  Treatment of salicylate poisoning with repeated oral charcoal. , 1985, British medical journal.

[9]  P. Neuvonen.  Clinical Pharmacokinetics of Oral Activated Charcoal in Acute Intoxications , 1982, Clinical pharmacokinetics.

[10]  V. Ringberger,et al.  Protein binding of salicylate in uremic and normal plasma , 1976, Clinical pharmacology and therapeutics.

[11]  L. E. Davis,et al.  Biotransformation and pharmacokinetics of salicylate in newborn animals. , 1973, American journal of veterinary research.

[12]  Davis Le,et al.  Species differences in biotransformation and excretion of salicylate. , 1972 .

[13]  P. K. Smith,et al.  Studies on the pharmacology of salicylates. , 1946, Federation proceedings.

[14]  S. Pond.  Role of Repeated Oral Doses of Activated Charcoal in Clinical Toxicology , 1986, Medical toxicology.

[15]  W. Watson,et al.  Gastrointestinal obstruction associated with multiple-dose activated charcoal. , 1986, The Journal of emergency medicine.

[16]  R. Curtis,et al.  Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose. , 1984, Archives of internal medicine.

[17]  Davis Le.  Clinical pharmacology of salicylates. , 1980 .